However, the Kaplan-Meyer survival analysis indicated a 2 week mortality rate after the histone challenge around 25% in the ADAMTS13 −/− group, which corresponds to a TTP model much less severe than in humans. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.